HORMONAL AND PERSONAL EFFECTS ON ESTROGEN RECEPTORS IN BREAST CANCER

Hulka, B. S. (Dept. of Epidemiology, U. of North Carolina, Chapel Hill, NC 27514), L. E. Chambless, W. E. Wilkinson, D. C. Deubner, K. S. McCarty, Sr. and K. S. McCarty, Jr. Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol 1984; 119: 692–704. Since high estrogen r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of epidemiology 1984-05, Vol.119 (5), p.692-704
Hauptverfasser: HULKA, BARBARA S., CHAMBLESS, LLOYD E., WILKINSON, WILLIAM E., DEUBNER, DAVID C., McCARTY, KENNETH S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hulka, B. S. (Dept. of Epidemiology, U. of North Carolina, Chapel Hill, NC 27514), L. E. Chambless, W. E. Wilkinson, D. C. Deubner, K. S. McCarty, Sr. and K. S. McCarty, Jr. Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol 1984; 119: 692–704. Since high estrogen receptor protein in breast cancer tissue has a favorable effect on patient prognosis, factors influencing estrogen receptor levels are the focus of this research. From April 1977 to December 1978, 246 histologically confirmed primary breast cancer patients from three North Carolina hospitals were interviewed and provided with photographic displays of hormonal products. Their tumor tissue was analyzed for estrogen receptor protein by the sucrose density gradient assay. Data were analyzed by multiple regression and logistic regression techniques. No statistically significant relationship was found between gonadal hormone usage and estrogen receptor levels, although recent users of either oral contraceptives or replacement estrogens had lower receptor levels. Users of progestogen-predominant and -intermediate types of oral contraceptives also had lower estrogen receptor protein. An effect of menopausal status, independent of age, was not evident. Statistically significant associations involved age and race among postmenopausal patients. With black breast cancer patients aged 10 fmol/mg of cytosol protein) were 2.4 times greater among whites aged
ISSN:0002-9262
1476-6256
DOI:10.1093/oxfordjournals.aje.a113790